How Canada is leading brain research and senior care with a $24 million centre

By Admin
A new brain research centre is expected to open in Ontario, Canada to support projects that enable healthier brain aging and allow seniors to live at ho...

A new brain research centre is expected to open in Ontario, Canada to support projects that enable healthier brain aging and allow seniors to live at home longer while reducing health care costs.

As reported by our sister brand Business Review Canada, the Canadian Centre for Aging and Brain Health Innovation at Baycrest Health Sciences will be established over the next five years and will effectively combine all of Baycrest’s brain research, clinical and educational programs into one convenient location.

RELATED TOPIC: Why do our brains get addicted?

The city of Ontario will invest $23.5 million into the establishment.

“Brain disorders take an enormous toll on a personal level, as well as on the economy,” said Kathleen Wynne, Premier of Ontario, in an issued release. “Our investment in this centre will allow new advances in brain research and care, cementing Ontario’s position as an innovation leader and ensuring that people can continue to lead healthy lives as they age.”

RELATED TOPIC: How Canada's stem cell research breakthrough will alter medical practices

The centre, scheduled to launch this fall, is one of the largest investments in senior care in the world.

“Our government is proud to support Baycrest Health Sciences and the new Canadian Centre for Aging and Brain Health Innovation,” added Reza Moridi, Minister of Research and Innovation. “We are committed to harnessing our research and commercialization strengths to attract investment and boost our economy, while helping seniors maintain their quality of life in the comfort of their own homes.”

In Ontario, the economic impact of brain and mental health disorders is estimated to cost more than $39 billion annually.

RELATED TOPIC: What to learn from the recent salmonella outbreak in Canada

The new centre will rise alongside the global market for brain health applications, software and biometrics, as the industry is poised to grow from $1 billion to $10 billion by the year 2020.

Let's connect!   

Read the latest edition of Healthcare Global magazine!

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma